Literature DB >> 17103314

Supraventricular tachyarrhythmia as a cause of sudden cardiac arrest.

B Brembilla-Perrot1, O Marçon, F Chometon, J Bertrand, A Terrier de la Chaise, P Louis, H Belhakem, H Blangy, O Claudon, O Selton, E Khaldi, N Sadoul, D Beurrier, M Abbas, M Andronache, M Abbas, N Zhang.   

Abstract

INTRODUCTION: Supraventricular tachyarrhythmias (SVTA) are an accepted cause of cardiac arrest in patients with Wolff-Parkinson-White syndrome (WPW) and hypertrophic cardiomyopathy but their participation in other conditions is less well understood. The purpose of the study was to examine the role of SVTA in sudden cardiac arrest (SCA) by comprehensive evaluation of patients successfully resuscitated from SCA.
METHODS: A total of 169 survivors of SCA in the absence of acute myocardial infarction underwent systematic evaluation that included echocardiography, Holter monitoring, coronary angiography and electrophysiological study (EPS) with additional testing in selected cases using provocative drug testing with isoproterenol, ajmaline or ergonovine.
RESULTS: SVTA was found as the only possible cause or as the cause facilitating SCA in 29 patients: (1) 3 had a WPW syndrome related to accessory pathway with short refractory period; (2) for 12 patients, SVTA was the cause of cardiovascular collapse; heart disease (HD) was present in 11 cases, but disappeared in two of four with dilated cardiomyopathy after the restoration of sinus rhythm; (3) in 14 patients, SVTA degenerated either in a VF or ventricular tachycardia (VT); HD was present in 12 cases, but disappeared in one; two had no HD and recurrent similar arrhythmia was documented by cardiac defibrillator in one of them. SVTA induced coronary ischemia was the main cause of SCA.
CONCLUSION: Rapid SVTA was a cause of SCA, either by cardiovascular collapse or by the degeneration in VT or VF. The complication generally occurred in patients with advanced HD or with rapid SVTA-induced cardiomyopathy and rarely in patients without HD. The incidence of SVTA as the only cause or the facilitating cause of SCAs is probably underestimated, because it is difficult to prove.

Entities:  

Mesh:

Year:  2006        PMID: 17103314     DOI: 10.1007/s10840-006-9042-4

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  31 in total

1.  Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH).

Authors:  K H Kuck; R Cappato; J Siebels; R Rüppel
Journal:  Circulation       Date:  2000-08-15       Impact factor: 29.690

2.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.

Authors:  Isabelle C Van Gelder; Vincent E Hagens; Hans A Bosker; J Herre Kingma; Otto Kamp; Tsjerk Kingma; Salah A Said; Julius I Darmanata; Alphons J M Timmermans; Jan G P Tijssen; Harry J G M Crijns
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

3.  Do atrial tachyarrhythmias beget ventricular tachyarrhythmias in defibrillator recipients?

Authors:  Kenneth M Stein; David E Euler; Rahul Mehra; Karlheinz Seidl; David J Slotwiner; Suneet Mittal; Steven M Markowitz; Bruce B Lerman
Journal:  J Am Coll Cardiol       Date:  2002-07-17       Impact factor: 24.094

4.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

5.  Sudden death during ambulatory electrocardiographic monitoring: importance of morphologic confirmation to establish cause of death.

Authors:  D J Kereiakes; F Morady; D Heath; T Parsons; M M Scheinman
Journal:  Am J Cardiol       Date:  1984-05-01       Impact factor: 2.778

6.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

Authors: 
Journal:  N Engl J Med       Date:  1997-11-27       Impact factor: 91.245

7.  Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.

Authors:  S J Connolly; M Gent; R S Roberts; P Dorian; D Roy; R S Sheldon; L B Mitchell; M S Green; G J Klein; B O'Brien
Journal:  Circulation       Date:  2000-03-21       Impact factor: 29.690

8.  Atrial induction of ventricular tachycardia: reentry versus triggered automaticity.

Authors:  D P Zipes; P R Foster; P J Troup; D H Pedersen
Journal:  Am J Cardiol       Date:  1979-07       Impact factor: 2.778

9.  Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trials.

Authors:  C M Pratt; P S Greenway; M H Schoenfeld; M L Hibben; J A Reiffel
Journal:  Circulation       Date:  1996-02-01       Impact factor: 29.690

10.  Patients with supraventricular tachycardia presenting with aborted sudden death: incidence, mechanism and long-term follow-up.

Authors:  Y S Wang; M M Scheinman; W W Chien; T J Cohen; M D Lesh; J C Griffin
Journal:  J Am Coll Cardiol       Date:  1991-12       Impact factor: 24.094

View more
  2 in total

Review 1.  Clinical Spectrum of PRKAG2 Syndrome.

Authors:  Andrea Giuseppe Porto; Francesca Brun; Giovanni Maria Severini; Pasquale Losurdo; Enrico Fabris; Matthew R G Taylor; Luisa Mestroni; Gianfranco Sinagra
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-01

2.  Atrioventricular reentrant tachycardia inducing ventricular fibrillation.

Authors:  Bernard Belhassen
Journal:  Eur Heart J Case Rep       Date:  2022-07-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.